San Diego-primarily based Viking Therapeutics marked itself as a serious competitor within the weight loss drug marketplace in February right after revealing promising data from the mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection and in March t